Diana, Anna
Carlino, Francesca
Giunta, Emilio Francesco
Franzese, Elisena
Guerrera, Luigi Pio
Di Lauro, Vincenzo
Ciardiello, Fortunato
Daniele, Bruno
Orditura, Michele
Funding for this research was provided by:
Università degli Studi della Campania Luigi Vanvitelli
Article History
Accepted: 18 February 2021
First Online: 16 April 2021
Declarations
:
: Anna Diana has received compensation from Roche, Doxopharma and Springer Healthcare for service as a consultant, and has received reimbursement for travel and accommodations from Roche, Istituto Gentili, Italfarmaco, Ipsen and Novartis.Francesca Carlino has received reimbursement for travel and accommodations from Italfarmaco.Emilio Francesco Giunta declares that he has no conflict of interest.Elisena Franzese declares that she has no conflict of interest.Luigi Pio Guerrera declares that he has no conflict of interest.Vincenzo Di Lauro declares that he has no conflict of interest.Fortunato Ciardiello declares that he has no conflict of interest.Bruno Daniele has received compensation from Ipsen, Eisai, Eli Lilly, AstraZeneca, Sanofi, MSD, Bayer, Roche and Amgen for service as a consultant, and he has received non-financial support from Ipsen, Sanofi and Bayer.Michele Orditura has received research funding from Genentech, Pfizer, Eisai and Novartis; has received compensation from Italfarmaco, Epionpharma, Eli Lilly, Tesaro, Genentech and MSD for service as a consultant/advisor; and has received reimbursement for travel and accommodations from Roche and Eisai.